The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
The global Huntington’s Disease Treatment market was valued at US$ 225.2 million in 2023 and is anticipated to reach US$ 1532.3 million by 2030, witnessing a CAGR of 30.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Huntington’s Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington’s Disease Treatment.
Report Scope
The Huntington’s Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Huntington’s Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington’s Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bausch Health
- Teva Pharmaceuticals
- Wave Life Sciences
- Ionis Pharmaceuticals/ Roche
- Raptor Pharmaceuticals
- Prana Biotechnology
Segment by Type
- Symptomatic Therapy
- Disease-Modifying Therapy
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Huntington’s Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Symptomatic Therapy
1.2.3 Disease-Modifying Therapy
1.3 Market by Application
1.3.1 Global Huntington’s Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Huntington’s Disease Treatment Market Perspective (2019-2030)
2.2 Huntington’s Disease Treatment Growth Trends by Region
2.2.1 Global Huntington’s Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Huntington’s Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Huntington’s Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Huntington’s Disease Treatment Market Dynamics
2.3.1 Huntington’s Disease Treatment Industry Trends
2.3.2 Huntington’s Disease Treatment Market Drivers
2.3.3 Huntington’s Disease Treatment Market Challenges
2.3.4 Huntington’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntington’s Disease Treatment Players by Revenue
3.1.1 Global Top Huntington’s Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Huntington’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Huntington’s Disease Treatment Revenue
3.4 Global Huntington’s Disease Treatment Market Concentration Ratio
3.4.1 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntington’s Disease Treatment Revenue in 2023
3.5 Huntington’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Huntington’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Huntington’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntington’s Disease Treatment Breakdown Data by Type
4.1 Global Huntington’s Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Huntington’s Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Huntington’s Disease Treatment Breakdown Data by Application
5.1 Global Huntington’s Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Huntington’s Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Huntington’s Disease Treatment Market Size (2019-2030)
6.2 North America Huntington’s Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Huntington’s Disease Treatment Market Size by Country (2019-2024)
6.4 North America Huntington’s Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Huntington’s Disease Treatment Market Size (2019-2030)
7.2 Europe Huntington’s Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Huntington’s Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Huntington’s Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Huntington’s Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Huntington’s Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Huntington’s Disease Treatment Market Size (2019-2030)
9.2 Latin America Huntington’s Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Huntington’s Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Huntington’s Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Huntington’s Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Huntington’s Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Huntington’s Disease Treatment Introduction
11.1.4 Bausch Health Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Introduction
11.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Wave Life Sciences
11.3.1 Wave Life Sciences Company Detail
11.3.2 Wave Life Sciences Business Overview
11.3.3 Wave Life Sciences Huntington’s Disease Treatment Introduction
11.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.3.5 Wave Life Sciences Recent Development
11.4 Ionis Pharmaceuticals/ Roche
11.4.1 Ionis Pharmaceuticals/ Roche Company Detail
11.4.2 Ionis Pharmaceuticals/ Roche Business Overview
11.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Introduction
11.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.4.5 Ionis Pharmaceuticals/ Roche Recent Development
11.5 Raptor Pharmaceuticals
11.5.1 Raptor Pharmaceuticals Company Detail
11.5.2 Raptor Pharmaceuticals Business Overview
11.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Introduction
11.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.5.5 Raptor Pharmaceuticals Recent Development
11.6 Prana Biotechnology
11.6.1 Prana Biotechnology Company Detail
11.6.2 Prana Biotechnology Business Overview
11.6.3 Prana Biotechnology Huntington’s Disease Treatment Introduction
11.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2019-2024)
11.6.5 Prana Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
